Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

FADU CEO Lee Ji-hyo set his company up for success well ahead of market relevance with its controllers for solid-state drives ...

Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering (IPO).

January 30, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for ...

Thursday marked the Nasdaq Global Market debut of Beta Bionics, Inc. as its initial public offering (IPO) opened for trading ...

FG Merger II Corp., a newly organized blank check company formed as a Nevada corporation, today announced the closing of its initial public offering ("IPO") of 8,000,000 units at an offering price of ...

Memory maker Kioxia Inc. is offering technology as open-source software claiming it will reduce generative AI's requirements for DRAM.

The initial share sale of 88.99 lakh shares will open for subscription on February 5 and close on February 7. The IPO is a combination of fresh issuance of 61.99 lakh shares worth Rs 58.27 crore, and ...

Tectonic Therapeutic (TECX) stock surges on positive interim data from Phase 1b trial for lead candidate TX45 in patients ...

Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial ...

As Brussels aims to promote investment in European innovation, it is vital that concerns about the role of the EU IP Office ...

CEO Jack Boys said the company is benefiting from investments in innovation and will open 30 to 40 more units in North America ...